Top Markets
Coin of the day
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Ранг среди акций #19054
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Цена акции
$1.27
Рыночная капитализация
$176.31M
Изменение (1 день)
5.57%
Изменение (1 год)
29.36%
Страна
TW
Торговля Medigen Biotechnology Corp. (3176)

Категория

Коэффициент P/B для Medigen Biotechnology Corp. (3176)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Medigen Biotechnology Corp., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Medigen Biotechnology Corp. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH